+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anavex Life Sciences Corp - logo

Anavex Life Sciences is a biopharmaceutical company that develops differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat diseases of the central nervous system, pain and various types of cancer. The company's best known product is ANAVEXTM 2-73, a compound being developed to treat Alzheimer's disease, Parkinson's disease and related diseases. The company was founded in 2006 and is based in New York.

From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 pages
From
Alzheimer's Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1785 pages
From
From
Prostate Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3323 pages
From
Fragile X Syndrome - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Fragile X Syndrome - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • May 2021
  • 84 pages
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 pages
From
Pain Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pain Drug Development Pipeline Review, 2018

  • Report
  • September 2018
  • 148 Pages
From
From
From
Rett Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Rett Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 178 pages
From
Rett Syndrome - Pipeline Insight, 2020 - Product Thumbnail Image

Rett Syndrome - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 868 pages
From
Fragile X Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Fragile X Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 194 pages
From
Parkinson's Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 1308 pages
From
Epilepsy - Pipeline Review, H2 2020 - Product Thumbnail Image

Epilepsy - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 662 pages
From
Loading Indicator
adroll